Executive Order 14292 Act of 2025
- Bill Number
- H.R. 3677
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Science, Technology, Communications
- Status
- Introduced
- Latest Action
- 2025-06-03: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Last Updated
- 2025-06-16T14:24:47Z
AI-Generated Summary
Purpose
This legislation, H.R. 3677 (titled the "Executive Order 14292 Act of 2025"), aims to convert Executive Order 14292—issued on May 5, 2025, to enhance the safety and security of biological research—into permanent federal law. By codifying the order, it ensures its directives are binding beyond the term of the issuing president, providing long-term stability to related policies.
Key Provisions
- Codification of Executive Order: The bill explicitly states that Executive Order 14292, which focuses on improving safety and security measures in biological research, will have the full force and effect of law.
- Short Title: The act is officially named the "Executive Order 14292 Act of 2025."
- Referral to Committees: The bill was introduced on June 3, 2025, by Representatives Burchett and Luna and referred to the House Committees on Energy and Commerce and Science, Space, and Technology for review.
Significant Changes to Existing Law
- This bill introduces no new substantive rules but transforms an executive action (the order) into statutory law, making its requirements enforceable through Congress rather than solely through presidential authority.
- It shifts the order's implementation from temporary executive policy to enduring federal statute, potentially requiring congressional oversight for future amendments rather than unilateral presidential changes.
Potential Impacts
- On Government Agencies: Agencies involved in biological research (e.g., those under the Department of Health and Human Services or the National Institutes of Health) may face formalized compliance obligations, including enhanced reporting, training, or risk assessments for research activities, leading to more structured oversight.
- On Citizens and Researchers: Scientists and institutions conducting biological research could experience stricter safety protocols to prevent accidents or misuse (e.g., lab leaks or bioterrorism risks), potentially increasing operational costs but improving public health protections.
- On International Relations: By solidifying U.S. standards for biological research security, it may influence global collaborations, encouraging or requiring international partners to align with these safeguards, which could affect joint research projects or aid in biosecurity.
Main Stakeholders Affected
- Federal Agencies and Research Institutions: Entities like the CDC, NIH, and universities performing federally funded biological research will need to integrate the order's safety and security guidelines into their operations.
- Researchers and Scientists: Individuals in biotechnology, virology, and related fields may encounter new compliance requirements affecting lab practices and funding eligibility.
- The Public: Citizens benefit indirectly through reduced risks from biological hazards, though taxpayers may see increased federal spending on enforcement.
- Congress and the Executive Branch: Lawmakers gain authority to modify the codified order, while the president loses sole discretion to revoke or alter it without legislative action.
Notable Legal, Constitutional, or Political Implications
- Legal Implications: Codification elevates the executive order to statutory status, making violations potentially subject to judicial enforcement and reducing challenges based on its temporary nature. It ensures continuity across administrations, avoiding policy reversals.
- Constitutional Implications: This reinforces the separation of powers by having Congress endorse and embed executive policy into law, aligning with Article I's legislative authority while respecting executive initiative in areas like national security.
- Political Implications: The bill could spark debates on the balance between innovation in biological research and security, especially amid concerns over pandemics or bioweapons. Its bipartisan introduction (by Burchett and Luna) suggests potential for broad support, but committee reviews may highlight tensions between research freedom and regulation.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (2)
Rep. Luna, Anna Paulina [R-FL-13], Rep. Self, Keith [R-TX-3]
Recent Actions
- 2025-06-03: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-06-03: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Science, Space, and Technology, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-06-03: Introduced in House
- 2025-06-03: Introduced in House
Bill Versions
- Executive Order 14292 Act of 2025 — issued 2025-06-03 — PDF (2 pages)